| Date | Title | Description | Source |
| 04.04.2024 | Relyvrio ALS Drug Withdrawn by Manufacturer Due to Lack of E... | Quincy Jon, Tech Times 04 April 2024, 02:04 pm
Amylyx Pharmaceuticals removed a Lou Gehrig's disease... | techtimes.... |
| 13.03.2024 | Investors Beware: Class Action Lawsuits Target GrafTech, Ins... | Bragar Eagel & Squire, P.C. is on the hunt for justice as they remind investors of the ongoing c... | parsers.vc... |
| 13.03.2024 | Amylyx Pharmaceuticals (AMLX) Tanks 80% After RELYVRIO ALS T... | - | globenewsw... |
| 12.03.2024 | How Do Companies Avert Further Frustration among Neurologist... | - | globenewsw... |
| 12.03.2024 | AMLX LAWSUIT ALERT: The Gross Law Firm Notifies Amylyx Pharm... | - | globenewsw... |
| 12.03.2024 | How Do Companies Avert Further Frustration among Neurologist... | Spherix Global Insights captures neurologists’ reactions within 48 hours of these pivotal announceme... | einpresswi... |
| 12.03.2024 | Bragar Eagel & Squire, P.C. Reminds Investors That Class... | - | globenewsw... |
| 11.03.2024 | ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Amylyx Pharm... | NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm,... | einpresswi... |
| 11.03.2024 | Kirby McInerney LLP Reminds Investors of Lead Plaintiff Dead... | - | globenewsw... |
| 10.03.2024 | AMLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC A... | - | globenewsw... |
| 08.03.2024 | Bragar Eagel & Squire, P.C. Reminds Investors That Class... | - | globenewsw... |
| 07.03.2024 | Amylyx Pharmaceuticals Class Action: Johnson Fistel Encourag... | - | globenewsw... |
| 07.03.2024 | ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Amylyx Pharmaceu... | - | globenewsw... |
| 07.03.2024 | DEADLINE ALERT: Bernstein Liebhard LLP Reminds Amylyx Pharma... | - | globenewsw... |
| 09.11.2023 | Eli Lilly tries a rare tactic: competing on price | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 23.01.2023 | Startups measuring the brain that you need to know | Companies are using biomarkers to diagnose and treat mental illness and other neurological disorders... | vator.tv/n... |
| 30.09.2022 | A controversial new drug to treat ALS just got approved by t... | (right to left) Joshua Cohen and Justin Klee, the cofounders and co-CEOs of Amylyx Pharmaceuticals. ... | businessin... |
| 26.09.2022 | A controversial ALS drug potentially worth $1 billion is on ... | (left to right) Joshua Cohen and Justin Klee, the cofounders and co-CEOs of Amylyx Pharmaceuticals. ... | businessin... |
| 08.09.2022 | In Rare Move, FDA Panel Gives Support to Controversial ALS D... | THURSDAY, Sept. 8, 2022 (HealthDay News) – In a rare second review, a U.S. Food and Drug Administrat... | salamancap... |
| 06.09.2022 | FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote
... | TUESDAY, Sept. 6, 2022 (HealthDay News) – A U.S. Food and Drug Administration panel will once again ... | salamancap... |
| 06.09.2022 | FDA Panel Skeptical of Controversial ALS Drug Ahead of Vote | TUESDAY, Sept. 6, 2022 (HealthDay News) -- A U.S. Food and Drug Administration panel will once again... | salamancap... |
| 16.08.2022 | As a pediatric cancer researcher, I admired the FDA. Then I ... | Amyotrophic lateral sclerosis (ALS), as I have unfortunately come to learn, is a terrible disease wi... | statnews.c... |
| 13.06.2022 | New ALS Drug Approved in Canada While Still Under FDA Review | MONDAY, June 13, 2022 (HealthDay News) -- An experimental drug for amyotrophic lateral sclerosis (AL... | salamancap... |
| 13.06.2022 | New ALS Drug Approved in Canada While Still Under FDA Review | MONDAY, June 13, 2022 (HealthDay News) -- An experimental drug for the neurological disorder ALS was... | salamancap... |
| 21.04.2022 | Will the shadow of Aduhelm cloud FDA’s decision-making on an... | On March 30, an FDA advisory panel voted 6 to 4 against recommending approval of what might be the m... | statnews.c... |
| 07.01.2022 | Amylyx Pharma’s IPO lands $190M as ALS drug begins FDA revie... | Amylyx Pharmaceuticals has joined the public markets with a $190 million IPO that will support the c... | medcitynew... |
| 21.07.2021 | Why did crypto exchange Binance exit FTX? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 21.07.2021 | Why did crypto exchange Binance exit FTX? | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 20.07.2021 | Amylyx Pharmaceuticals raises $135M as ALS drug heads to piv... | Amylyx Pharmaceuticals showed in a clinical trial that its amyotrophic lateral sclerosis (ALS) drug ... | medcitynew... |
| 20.07.2021 | Amylyx Pharmaceuticals Raises $135M in Series C Financing | Amylyx Pharmaceuticals, Inc., a Cambridge, MA-based pharmaceutical company, closed $135m in Series C... | finsmes.co... |
| 20.07.2021 | Amylyx Pharmaceuticals Inks $135M Series C |
CAMBRIDGE, MA, Amylyx Pharmaceuticals today announced the closing of an oversubscribed $135 millio... | vcnewsdail... |
| 20.07.2021 | Amylyx Pharmaceuticals Closes $135M Series C Financing Led b... | Amylyx Pharmaceuticals, Inc. today announced the closing of an oversubscribed $135 million Series C ... | marketscre... |
| 20.07.2021 | Amylyx raises $135M to gear up for potential Canadian launch... | A month after filing for Canadian approval for its lead ALS candidate, Amylyx Pharmaceuticals has pi... | fiercebiot... |
| 22.06.2021 | FDA should lead the way on new ALS treatments, not Canada an... | Following the Food and Drug Administration’s recent decision to give the green light to aducanumab, ... | statnews.c... |
| 11.05.2021 | Fast-Growing Network Life Science Platform Company, Eagle Ge... | The successful British scale-up has attracted senior figures in international business development, ... | marketscre... |
| 01.07.2020 | Amylyx Pharmaceuticals Raises $30 Million in Series B Fundin... | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc., a pharmaceutical company focused on... | citybizlis... |
| 01.07.2020 | Amylyx Pharmaceuticals Raises $30M in Series B |
CAMBRIDGE, MA, Amylyx Pharmaceuticals has closed an oversubscribed $30 million Series B financing,... | vcnewsdail... |
| 22.08.2016 | Amylyx Raises $5M in Series A Funding | Amylyx Pharmaceuticals Inc., a Cambridge, MA-based developer of a novel therapeutic for Amyotrophic ... | finsmes.co... |
| 22.08.2016 | Amylyx Raises $5 Million Series A | CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals Inc. announced today that it has completed... | citybizlis... |
| 17.11.2015 | Amylyx gets $1.9M for ALS, Alzheimer’s drug that mediates or... | “The ALS Finding a Cure Foundation is committed to pursuing multiple avenues toward a cure for ALS,”... | medcitynew... |
| - | Amylyx Pharma’s IPO lands $190M as ALS drug begins FDA revie... | Amylyx Pharmaceuticals has joined the public markets with a $190 million IPO that will support the c... | medcitynew... |
| - | Amylyx gets $1.9M for ALS, Alzheimer’s drug that mediates or... | Cambridge startup Amylyx Pharmaceuticals is developing a new combination drug product that could hel... | medcitynew... |
| - | Amylyx Pharmaceuticals raises $135M as ALS drug heads to piv... | Amylyx Pharmaceuticals showed in a clinical trial that its amyotrophic lateral sclerosis (ALS) drug ... | medcitynew... |
